Silo Pharma Receives European Patent Allowance for Licensed Novel PTSD Prevention Therapy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. PRIM
2. ABBV
3. IBM
4. META
5. DPZ
6. DFTX
7. CNC
8. KFY
9. SPY
10. MU

Go back to Silo Pharma Receives European Patent Allowance for Licensed Novel PTSD Prevention Therapy
(NASDAQ: SILO) Delayed: 6.02 --0 (-0%)
Previous Close $6.02    52 Week High $ 
Open $6.02    52 Week Low $ 
Day High $6.02    P/E N/A 
Day Low $6.02    EPS $ 
Volume 13